The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update - April 2016

13 Apr 2016 11:00

RNS Number : 0782V
Honeycomb Investment Trust PLC
13 April 2016
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

13 April 2016

 

 

Honeycomb Investment Trust plc ("Honeycomb" or the "Company")

Trading update

 

Further to the portfolio acquisition announcement of 7 April 2016 (the "April Portfolio Acquisition"), Honeycomb is releasing a trading update.

 

Based on the investments it has committed to and the currently available pipeline of investment opportunities, Honeycomb expects that the unlevered, net annual returns on loan investments as at full deployment of its IPO equity raise proceeds will be 12% or greater (after expected default losses and servicing costs), which compares favourably to the Company's targeted annual net return on loan investments of 10% or greater.

 

Since its IPO in late December 2015, the Company has been investing its capital quickly and effectively and is well on track to be fully deployed ahead of the six to nine month period targeted. On completion of the April Portfolio Acquisition, the Company's investment activity will have consisted of:

 

· Approximately £85 million invested in assets across portfolios and through organic origination partnerships;

· A diversified and seasoned portfolio of over 32,000 loans to UK borrowers;

· Regular origination is now occurring, principally through Freedom Finance at this stage, and a further 3 origination partners are being contracted with. Pay4Later has progressed well and retailer opportunities are being presented. Origination remains on track to increase to greater than £4m per month with a volume mix in line with expectations; and

· The intended investment in Pay4Later disclosed in the Company's IPO prospectus is expected to complete later this month, which will take equity investments up to approximately £4.7 million.

 

The Company continues to progress discussions and documentation with two major UK banks for the provision of up to £75 million of credit facilities to the Company, with the expectation of concluding the first facility, of approximately £40 million, within the coming weeks.

 

The Company targets dividends of 8% or greater on its shares issue price when fully invested and levered. Based on the expected net returns on loan investments being currently higher than targeted, the Company expects dividends, once fully invested and levered, will be at a rate of 10% or greater of its shares issue price; expected to be achieved for Q3 period of 2016.

 

Honeycomb continues to see a strong pipeline of opportunities to deploy funds in line with its returns targets, via the ongoing origination partnerships it has established and others it expects to add going forwards, as well as through further portfolio acquisitions, including the proposed acquisition of the second portfolio referred to in the April Portfolio Acquisition announcement. In light of this, the Company is now actively considering an issue of additional equity, subject to prevailing market conditions and investor demand.

 

Lindsey McMurray, chief executive of Pollen Street Capital Limited, investment manager of the Company, said: "We are glad to say Honeycomb has been delivering ahead of the plan set out to investors at its IPO. The first dividend is intended to be declared in May, and the prompt deployment of funds means that Honeycomb can move towards providing its shareholders with dividends ahead of its target during this year.

 

Opportunities continue to be strong in both portfolio acquisitions and organic origination through focusing on delivering high quality lending products in under-served markets"

 

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate.

 

This announcement contains certain statements about the future plans of the Company and expectations relating to its future financial condition, performance, results, strategy and objectives. These forward looking statements are based on the Company's current plans and expectations, and accordingly may be influenced by a number of factors that could cause actual outcomes to be materially different. The Company expressly disclaims any obligation to update any of the forward looking statements in this announcement

 

Enquiries:

Apex Fund Services (UK) Ltd.

Priya Dhaliah / Paul Spendiff / Robert Kelly020 3697 5368

Pollen Street Capital Limited

Chris Palmer / Johnathan Moyes020 3728 6750

Liberum

Simon Atkinson / Chris Clarke / Joshua Hughes020 3100 2000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUGCGDSIUBBGLX
Date   Source Headline
1st Nov 20213:58 pmRNSDirector Declaration
28th Oct 202110:42 amRNSNAV and Monthly Update August 2021 - Replacement
28th Oct 20217:00 amRNSNAV and Monthly Update September 2021
20th Oct 202111:57 amRNSHolding(s) in Company
1st Oct 20217:05 amRNSDirector Declaration
29th Sep 20217:00 amRNSNAV and Monthly Update September 2021
15th Sep 20217:00 amRNSHalf-year Report
8th Sep 20214:53 pmRNSNotification of Board Committee Changes
8th Sep 20217:00 amRNSDividend Declaration
7th Sep 20217:00 amRNSNAV and Monthly Update - July 2021
28th Jul 20217:00 amRNSNAV and Monthly Update - June 2021
29th Jun 20217:00 amRNSNAV and Monthly Update - May 2021
8th Jun 20215:15 pmRNSResult of AGM
28th May 20219:39 amRNSDirector/PDMR Shareholding
27th May 20217:00 amRNSNAV and Monthly Update - April 2021
14th May 202111:54 amRNSDirector/PDMR Shareholding
10th May 20214:53 pmRNSPosting of Annual Report and Notice of AGM
30th Apr 20217:02 amRNSAnnual Report and Audited Financial Statements
30th Apr 20217:01 amRNSDividend Declaration
30th Apr 20217:00 amRNSNAV and Monthly Update - March 2021
1st Apr 20217:00 amRNSNAV and Monthly Update - February 2021
4th Mar 20217:00 amRNSNAV and Monthly Update - January 2021
26th Feb 20217:00 amRNSDividend Declaration
25th Feb 20214:14 pmRNSBoard Committee Changes & SID Appointment
12th Feb 20217:00 amRNSNAV and Monthly Update - December 2020
12th Jan 20211:43 pmRNSHolding(s) in Company
12th Jan 20211:40 pmRNSHolding(s) in Company
12th Jan 202111:38 amRNSHolding(s) in Company
7th Jan 20217:00 amRNSNAV and Monthly Update - November 2020
29th Dec 202012:22 pmRNSDirectorate Change
18th Dec 202010:21 amRNSKepler Trust Intelligence: New Research
1st Dec 20207:01 amRNSMonthly Update – October 2020
1st Dec 20207:00 amRNSNet Asset Value(s)
20th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Nov 20207:00 amRNSDividend Declaration
19th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
18th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Nov 20204:54 pmRNSHolding(s) in Company
13th Nov 202011:11 amRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
12th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
11th Nov 20207:00 amRNSShare Buy-Back Programme
6th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
4th Nov 20207:01 amRNSMonthly Update - September 2020
4th Nov 20207:00 amRNSNet Asset Value(s)
4th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Nov 20205:01 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.